<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Managing the Chain of Identity in Cell Therapeutics Manufacturing</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/managing-the-chain-of-identity-in-cell-therapeutics-manufacturing-1073239609</link><description>Medicines produced by pharmaceutical and biotech manufacturers are manufactured in many ways. One particular type of treatment, cell therapy, is defined as :
 
 
 …the transplantation of human or animal cells to replace or repair damaged tissue.
 
 
</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>